|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/755 | |
| A61K 38/00 | |||
| A61K 38/37 | |||
| A61K 47/60 |
| (11) | Number of the document | 3323829 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17201672.7 |
| Date of filing the European patent application | 2005-11-14 | |
| (97) | Date of publication of the European application | 2018-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 627277 P | 2004-11-12 | US |
| (72) |
PAN, Clark Q., US
MURPHY, John E., US
MEI, Baisong, US
STRAUSS, Jonathan S., US
TJANDRA, Hendri, US
CHEN, Jianmin, US
BARNETT, Thomas, US
TANG, Liang, US
WANG, Deqian, US
|
| (73) |
Bayer HealthCare LLC,
555 White Plains Road, Tarrytown, NY 10591,
US
|
| (54) | SITE-DIRECTED MODIFICATION OF FVIII |
| SITE-DIRECTED MODIFICATION OF FVIII |